$2.02
-0.04-1.93%
Last update: 11:00 AM
15 minutes delayed
Ocuphire Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ocuphire Pharma using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma | -$0.24 | -$0.24 | — | — | $3.67M | $2.61M | — | — | 08/09/2024 | Get Alert |
OCUP | Ocuphire Pharma | -$0.28 | -$0.13 | -$0.29 | -123.08% | $1.75M | $4.25M | $1.71M | -59.74% | 05/10/2024 | Get Alert |
OCUP | Ocuphire Pharma | $1.63 | -$0.05 | -$0.21 | -320.00% | $39.85M | $5.35M | $1.69M | -68.39% | 03/08/2024 | Get Alert |
OCUP | Ocuphire Pharma | -$0.22 | -$0.22 | $0.25 | 213.64% | $0.00 | $3.02M | $11.94M | 295.20% | 11/13/2023 | Get Alert |
OCUP | Ocuphire Pharma | -$0.25 | -$0.23 | -$0.24 | -4.35% | $0.00 | $2.42M | $3.67M | 51.82% | 08/11/2023 | Get Alert |
OCUP | Ocuphire Pharma | -$0.35 | -$0.15 | -$0.28 | -86.67% | $0.00 | $2.95M | $1.75M | -40.71% | 05/15/2023 | Get Alert |
OCUP | Ocuphire Pharma | -$0.35 | $0.97 | $1.63 | 68.04% | $0.00 | $29.44M | $39.85M | 35.36% | 03/30/2023 | Get Alert |
OCUP | Ocuphire Pharma | -$0.25 | -$0.29 | -$0.22 | 24.14% | $489.00K | — | $0.00 | — | 11/04/2022 | Get Alert |
OCUP | Ocuphire Pharma | -$0.52 | — | -$0.25 | — | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
OCUP | Ocuphire Pharma | -$0.47 | — | -$0.35 | — | $0.00 | — | $0.00 | — | 05/13/2022 | Get Alert |
OCUP | Ocuphire Pharma | -$2.46 | -$0.29 | -$0.35 | -20.69% | $0.00 | — | $0.00 | — | 03/24/2022 | Get Alert |
OCUP | Ocuphire Pharma | -$0.33 | -$0.36 | -$0.25 | 30.56% | $0.00 | — | $489.00K | — | 11/12/2021 | Get Alert |
OCUP | Ocuphire Pharma | -$0.43 | -$0.37 | -$0.52 | -40.54% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
OCUP | Ocuphire Pharma | -$0.93 | -$0.71 | -$0.47 | 33.80% | $0.00 | — | $0.00 | — | 05/07/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-10 | $-0.29 | $-0.13 | -123.1 % |
Dec 2023 | 2024-03-08 | $-0.21 | $-0.05 | -320.0 % |
Sep 2023 | 2023-11-13 | $0.25 | $-0.22 | 213.6 % |
Jun 2023 | 2023-08-11 | $-0.24 | $-0.23 | -4.35 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-10 | $1.71M | $4.25M | -59.7 % |
Dec 2023 | 2024-03-08 | $1.69M | $5.35M | -68.4 % |
Sep 2023 | 2023-11-13 | $11.94M | $3.02M | 295.2 % |
Jun 2023 | 2023-08-11 | $3.67M | $2.42M | 51.8 % |
Ocuphire Pharma (OCUP) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 10, 2024 for Q1.
The Actual EPS was $-0.29, which missed the estimate of $-0.13.
The Actual Revenue was $1.7M, which missed the estimate of $4.3M.
Browse earnings estimates, EPS, and revenue on all stocks.